Ares Financial Consulting’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-25
Closed -$932 – 1100
2026
Q2
$932 Buy
+25
New +$765 ﹤0.01% 1017

Other funds holding IDYA

Ares Financial Consulting's IDYA Position: Q3 2026 in Review

Ares Financial Consulting sold out of IDEAYA Biosciences (IDYA) in Q3 2026, closing a stake of 25 shares — an estimated $932 sold.

Ares Financial Consulting first reported a position in IDYA in Q2 2026 and held it in 1 quarter. The position peaked at $932 in Q2 2026. 280 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Ares Financial Consulting reported no remaining IDEAYA Biosciences position as of Q3 2026 after selling out during the quarter.
  • Ares Financial Consulting sold 25 IDEAYA Biosciences shares in Q3 2026, an estimated $932.
  • Ares Financial Consulting first reported a position in IDEAYA Biosciences in Q2 2026 and held it in 1 quarter.
  • Ares Financial Consulting's IDEAYA Biosciences position peaked at $932 in Q2 2026.
  • 280 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.